‌

US Patent 9326936 Aerosol fluoroquinolone formulations for improved pharmacokinetics

Patent 9326936 was granted and assigned to Raptor Pharmaceuticals on May, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Patent Applicant

Raptor Pharmaceuticals

Current Assignee

Raptor Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9326936

Date of Patent

May 3, 2016

Patent Application Number

14333583

Date Filed

July 17, 2014

Patent Primary Examiner

‌

Savitha Rao

Patent abstract

The present invention relates to the field of antimicrobial agents. In particular, the present invention relates to the use of aerosolized fluoroquinolones formulated with divalent or trivalent cations and having improved pulmonary availability for the treatment and management of bacterial infections of the lung and upper respiratory tract.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9326936 Aerosol fluoroquinolone formulations for improved pharmacokinetics

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API